What drug did Novartis sell to GlaxoSmithKline in 2015?
Ritalin
Exjade
Voltaren
Gleevec
Answer
In 2015, Novartis sold the rights to the drug diclofenac, marketed as Voltaren, to GlaxoSmithKline. This is part of the company's strategic moves to focus on its core businesses.
Unveiling Novartis: A Pharmacological Odyssey
More Questions
Which company did Novartis form a partnership with to spin out Syngenta?
What is the name of the drug Novartis manufactures to treat breast cancer?
In what year was Novartis formed through a merger?
What is the name of the drug Novartis manufactures to treat iron overload?
What was the name of the company that Novartis spun off as an independent entity after the merger?
Related Quizzes
Subscribe Now!
Learn something
new everyday
Playing quizzes is free! We send 1 quiz every week to your inbox